FDA Fast-Tracks Eli Lilly's Obesity Pill Foundayo
The U.S. FDA has granted accelerated approval to Eli Lilly's weight-loss medication Foundayo, targeting obesity. This move highlights growing efforts to address the global obesity crisis with innovative pharmaceutical solutions.


